0001104659-20-113579.txt : 20201008 0001104659-20-113579.hdr.sgml : 20201008 20201008202731 ACCESSION NUMBER: 0001104659-20-113579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201007 FILED AS OF DATE: 20201008 DATE AS OF CHANGE: 20201008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LLOYD RONALD K. CENTRAL INDEX KEY: 0001644078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 201231905 MAIL ADDRESS: STREET 1: C/O MALLINCKRODT PHARMACEUTICALS STREET 2: 675 MCDONNELL BLVD. CITY: HAZELWOOD STATE: MO ZIP: 63042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 4 1 a4.xml 4 X0306 4 2020-10-07 0 0001708527 AZIYO BIOLOGICS, INC. AZYO 0001644078 LLOYD RONALD K. C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 1 1 0 0 President and CEO Stock Option (Right to Buy) 17.00 2020-10-07 4 A 0 181783 0.00 A 2030-10-06 Class A Common Stock 181783 181783 D Restricted Stock Units 2020-10-07 4 A 0 100425 0.00 A Class A Common Stock 100425 100425 D This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. /s/ Ronald Lloyd 2020-10-08